Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Peripheral arterial intervention · Rhode Island | Peripheral arterial intervention · New York | |
|---|---|---|
| Surgeons, 2024 | 4 | 97 |
| Medicare fee-for-service cases | 346 | 12,468 |
| Growth since 2019 (Medicare FFS) | −12%/yr | −0.1%/yr |
| Forecast cases (Medicare FFS) | 380 in 2030 | 16,300 in 2030 |
| Forecast growth | +1.5%/yr to 2030 | +4.6%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 3.6 | 6.5 |
| Medicare Advantage share | 66% | 57% |
| Out of hospital | 54% | 60% (+12 pts since 2019) |
| Cases per surgeon | 87 | 129 |
| Top 10 surgeons' share | 100% | 43% |
| Surgeons growing | 1 | 13 |
| New since the base year | 1 | 22 |
| Likely to stop billing it | 2 by 2026 | 23 by 2026 |
| Forecast miss, 1 year (procedure) | 8% | 8% |
| Company payments per surgeon | $542 | $3,358 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.